Karin Eastham, Director at NEKTAR THERAPEUTICS (NKTR), sold 42,534 shares at $3.61 ($154K) on 2022-09-13, disclosed to the SEC on 2022-09-14.
Seasonal sale ($154k) by Director — this insider has traded NKTR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.61 | 21,267 | $77K | 50.0% |
| 2 | $3.61 | 21,267 | $77K | 50.0% |
| Total | $3.61 avg | 42,534 | $154K | 100% |
| Filing → |
| VCYT | SELL | 2025-11-07 | $774K | — | Filing → |
| VCYT | SELL | 2025-06-17 | $245K | — | Filing → |
| VCYT | SELL | 2025-01-06 | $806K | — | Filing → |